Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elevation Oncology, Inc.

0.3802
0.0000
Volume:170.53K
Turnover:64.72K
Market Cap:22.53M
PE:-0.47
High:0.3826
Open:0.3755
Low:0.3755
Close:0.3802
Loading ...

TD Cowen Downgrades Elevation Oncology to Hold From Buy

MT Newswires Live
·
10 Jun

Correction: HC Wainwright Downgrades Elevation Oncology to Neutral From Buy

MT Newswires Live
·
10 Jun

Elevation Oncology, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
10 Jun

U.S. RESEARCH ROUNDUP-Crane, Ryder System, Terex

Reuters
·
10 Jun

Elevation Oncology Inc : TD Cowen Cuts to Hold From Buy

THOMSON REUTERS
·
10 Jun

Elevation Oncology downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
10 Jun

Elevation Oncology Cut to Market Perform From Outperform by William Blair

Dow Jones
·
10 Jun

Elevation Oncology Inc : William Blair Cuts to Market Perform Rating

THOMSON REUTERS
·
09 Jun

Elevation Oncology to Be Acquired by Concentra Biosciences for $0.36 Per Share Plus Contingent Value Rights

Reuters
·
09 Jun

Elevation Oncology Enters Into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right

THOMSON REUTERS
·
09 Jun

Elevation Oncology Inc - Board Unanimously Approves Merger Agreement

THOMSON REUTERS
·
09 Jun

Elevation Oncology: Hold Rating Amid Strategic Uncertainty and Financial Constraints

TIPRANKS
·
19 May

Elevation Oncology Reports Q1 2025 Financial Results

TIPRANKS
·
17 May

Elevation Oncology Inc : Piper Sandler Cuts Target Price to $0.5 From $0.7

THOMSON REUTERS
·
15 May

Elevation Oncology Q1 EPS $(0.24) Misses $(0.19) Estimate

Benzinga
·
15 May

Elevation Oncology Reports Increased R&D Expenses in Q1 2025; Maintains Cash Runway into 2H 2026

Reuters
·
15 May

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

THOMSON REUTERS
·
15 May

Elevation Oncology Q1 Income From Operations USD -14.216 Million

THOMSON REUTERS
·
15 May

Elevation Oncology Inc - Restructuring Charges Were $3.4 Mln for Q1 2025

THOMSON REUTERS
·
15 May

Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

PR Newswire
·
26 Apr